Does hyperphenylalaninemia induce brain glucose hypometabolism?

• Verfasst von: Trefz, Friedrich K. [VerfasserIn]
• Verfasst von: Frauendienst-Egger, Georg [VerfasserIn]
• Verfasst von: Dienel, Gerald [VerfasserIn]
• Verfasst von: Cannet, Claire [VerfasserIn]
• Verfasst von: Schmidt-Mader, Brigitte [VerfasserIn]
• Verfasst von: Haas, Dorothea [VerfasserIn]
• Verfasst von: Blau, Nenad [VerfasserIn]
• Verfasst von: Himmelreich, Nastassja [VerfasserIn]
• Verfasst von: Spraul, Manfred [VerfasserIn]
• Verfasst von: Freisinger, Peter [VerfasserIn]
• Verfasst von: Dobrowolski, Steven [VerfasserIn]
• Verfasst von: Berg, Daniela [VerfasserIn]
• Verfasst von: Pilotto, Andrea [VerfasserIn]
• Titel: Does hyperphenylalaninemia induce brain glucose hypometabolism?
• Titelzusatz: Cerebral spinal fluid findings in treated adult phenylketonuric patients
• Verf.angabe: Friedrich Trefz, Georg Frauendienst-Egger, Gerald Dienel, Claire Cannet, Brigitte Schmidt-Mader, Dorothea Haas, Nenad Blau, Nastassja Himmelreich, Manfred Spraul, Peter Freisinger, Steven Dobrowolski, Daniela Berg, Andrea Pilotto
• E-Jahr: 2024
• Jahr: 23 March 2024
• Umfang: 11 S.
• Illustrationen: Illustrationen
• Fussnoten: Gesehen am 26.03.2025
• Titel Quelle: Enthalten in: Molecular genetics and metabolism
• Ort Quelle: Orlando, Fla. : Academic Press, 1998
• Jahr Quelle: 2024
• Band/Heft Quelle: 142(2024), 1 vom: Mai, Artikel-ID 108464, Seite 1-11
• ISSN Quelle: 1096-7206
• DOI: doi:10.1016/j.ymgme.2024.108464
• Datenträger: Online-Ressource
• Sprache: eng
• Sach-SW: Adult
• Sach-SW: Blood Glucose
• Sach-SW: Brain
• Sach-SW: Cerebral spinal fluid
• Sach-SW: Female
• Sach-SW: Glucose
• Sach-SW: Glutamine
• Sach-SW: Humans
• Sach-SW: Lactate
• Sach-SW: Lactic Acid
• Sach-SW: Male
• Sach-SW: Phenylalanine
• Sach-SW: Phenylketonuria
• Sach-SW: Phenylketonurias
• Sach-SW: Plasma
• Sach-SW: Young Adult
• K10plus-PPN: 1920626786

Abstract

Despite numerous studies in human patients and animal models for phenylketonuria (PKU; OMIM#261600), the pathophysiology of PKU and the underlying causes of brain dysfunction and cognitive problems in PKU patients are not well understood. In this study, lumbar cerebral spinal fluid (CSF) was obtained immediately after blood sampling from early-treated adult PKU patients who had fasted overnight. Metabolite and amino acid concentrations in the CSF of PKU patients were compared with those of non-PKU controls. The CSF concentrations and CSF/plasma ratios for glucose and lactate were found to be below normal, similar to what has been reported for glucose transporter1 (GLUT1) deficiency patients who exhibit many of the same clinical symptoms as untreated PKU patients. CSF glucose and lactate levels were negatively correlated with CSF phenylalanine (Phe), while CSF glutamine and glutamate levels were positively correlated with CSF Phe levels. Plasma glucose levels were negatively correlated with plasma Phe concentrations in PKU subjects, which partly explains the reduced CSF glucose concentrations. Although brain glucose concentrations are unlikely to be low enough to impair brain glucose utilization, it is possible that the metabolism of Phe in the brain to produce phenyllactate, which can be transported across the blood-brain barrier to the blood, may consume glucose and/or lactate to generate the carbon backbone for glutamate. This glutamate is then converted to glutamine and carries the Phe-derived ammonia from the brain to the blood. While this mechanism remains to be tested, it may explain the correlations of CSF glutamine, glucose, and lactate concentrations with CSF Phe.